This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Attention HITK Shareholders: The Proposed Buyout Of Hi-Tech Pharmacal Co., Inc. By Akorn, Inc. Under Investigation By The Young Law Firm

The Young Law Firm, a leading national shareholder litigation firm, is investigating possible claims concerning the proposed acquisition of Hi-Tech Pharmacal Co., Inc. by Akorn, Inc. The investigation concerns whether the directors of Hi-Tech Pharmacal have obtained fair value for the sale of the Company and have fulfilled their fiduciary duties to the Company’s shareholders in connection with the proposed sale.

Pursuant to the terms of the proposed transaction, shareholders of Hi-Tech Pharmacal Co., Inc. (Nasdaq: HITK) will receive $43.50 per share in cash. The transaction is valued at approximately $640 million.

Individual shareholders have rights. The Young Law Firm is seeking active and engaged shareholders interested in ensuring that their rights are being protected. If you own shares of the Company and would like to learn more about the buyout of Hi-Tech Pharmacal, or have information about the proposed transaction, please contact:

Henry Young Esq. The Young Law Firm Toll Free: (888) 452-7252 Email: contact@theyounglf.com or visit: www.mergersbuyoutsandfraud.com/hitech-pharmacal-buyout-merger-shareholder-lawsuit-hitk/

Henry Young Esq., the Firm’s founder, has over 10 years of experience litigating complex shareholder class action lawsuits, including cases resulting in the recovery of millions of dollars for shareholders. The Firm routinely works with and refers cases to other leading law firms around the country to enforce shareholder rights. For more information about the Firm and class action cases in general, please visit our website: www.theyounglf.com.

This press release may be considered attorney advertising. Past results do not guarantee future performance.



Copyright Business Wire 2010

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs